{"podcast":{"title":"Paul Talks Science","slug":"paul-talks-science-7078474","podcast_index_feed_id":7078474,"rss_url":"https://anchor.fm/s/f816aa78/podcast/rss","website_url":"https://paultalks.science/","image_url":"https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_nologo/41522350/41522350-1736370912805-a80f9ca4bd96c.jpg","author":"Paul ADEPOJU, PhD","episode_count":60,"summary":"Welcome to \"Paul Talks Science,\" a podcast that journeys into the ever-evolving realms of health, science, and innovation. Hosted by Paul Adepoju, each episode features thought-provoking conversations with experts and trailblazers who are shaping the future of medicine and technology. From groundbreaking research to revolutionary treatments, \"Paul Talks Science\" delves deep into the stories and ideas that will define tomorrow's world. Join us as we explore the cutting edge, challenge the status quo, and uncover the innovations that hold the promise of a better, healthier future.","last_synced_at":"2026-07-15T08:20:45.692868+00:00","page_url":"https://stenobird.com/podcast/paul-talks-science-7078474"},"episode":{"title":"Resistance, Regulation, and Reformulation: Malaria’s Next Scientific Chapter","slug":"resistance-regulation-and-reformulation-malaria-s-next-scientific-chapter","published_at":"2025-08-18T05:00:01+00:00","page_url":"https://stenobird.com/podcast/paul-talks-science-7078474/resistance-regulation-and-reformulation-malaria-s-next-scientific-chapter","show_page_url":"https://stenobird.com/podcast/paul-talks-science-7078474","url":"https://podcasters.spotify.com/pod/show/paul-talks-science/episodes/Resistance--Regulation--and-Reformulation-Malarias-Next-Scientific-Chapter-e36viot","audio_url":"https://anchor.fm/s/f816aa78/podcast/play/106989789/https%3A%2F%2Fd3ctxlq1ktw2nl.cloudfront.net%2Fstaging%2F2025-7-17%2F405822080-44100-2-be4d014f9e841.m4a","summary":"In this episode of Paul Talks Science , Paul Adepoju sits down with Adam Aspinall, Senior Director of Access & Product Management at Medicines for Malaria Venture (MMV) . They discuss the science and strategy behind a groundbreaking new malaria drug for newborns and young children — the first of its kind. From how scientists reformulated existing treatments to meet the needs of infants, to the global regulatory pathways that made rapid approval possible, this conversation sheds light on the innovation, policy, and persistence shaping the future of malaria control.","meta_description":"In this episode of Paul Talks Science , Paul Adepoju sits down with Adam Aspinall, Senior Director of Access & Product Management at Medicines for Mal…","key_points":[],"chapters":[],"topics":[],"duration_seconds":1289,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/paul-talks-science-7078474/episodes/resistance-regulation-and-reformulation-malaria-s-next-scientific-chapter/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/paul-talks-science-7078474/resistance-regulation-and-reformulation-malaria-s-next-scientific-chapter.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}